Givaudan SA (OTCMKTS:GVDNY - Get Free Report) was the recipient of a significant drop in short interest in July. As of July 31st, there was short interest totaling 800 shares, adropof91.5% from the July 15th total of 9,400 shares. Currently,0.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 195,900 shares, the short-interest ratio is currently 0.0 days. Based on an average daily trading volume, of 195,900 shares, the short-interest ratio is currently 0.0 days. Currently,0.0% of the shares of the stock are sold short.
Givaudan Price Performance
GVDNY stock traded down $0.60 during trading on Thursday, reaching $82.15. 40,268 shares of the stock were exchanged, compared to its average volume of 29,614. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.49 and a quick ratio of 0.98. The business has a 50 day moving average price of $93.99 and a 200-day moving average price of $92.33. Givaudan has a 1 year low of $81.37 and a 1 year high of $110.32.
Analysts Set New Price Targets
Separately, Barclays raised shares of Givaudan from a "strong sell" rating to a "hold" rating in a research note on Tuesday, July 8th.
Check Out Our Latest Stock Report on Givaudan
About Givaudan
(
Get Free Report)
Givaudan SA manufactures, supplies, and sells fragrance, beauty, taste, and wellbeing products to the consumer goods industry. The company operates through divisions, Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division offers fine fragrances; consumer products, such as personal, home, fabric, and oral care; fragrance ingredients; and active beauty products.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Givaudan, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Givaudan wasn't on the list.
While Givaudan currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.